medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2002, Number 2

<< Back

Alerg Asma Inmunol Pediatr 2002; 11 (2)

Risk factors for development of asthma and other allergic diseases

Rojas GA

Language: Spanish
References: 50
Page: 67-75
PDF size: 108.94 Kb.


ABSTRACT

Asthma, eczema and hay fever are characterized by abnormal reactions to common allergens, which are mediated by immunoglobulin E. These allergic diseases are increasing in prevalence. They are the result of complex interactions between largely unknown genetic and environmental mechanisms. The first exposure to allergens, which may have an impact on the development of atopic disease many years later, takes place during a period when the immune system is poorly developed. Recognition of the risk factors for allergy is important in order to select the factors that could be modified for individuals at risk and in order to identify those factors of which the modulation could evolve in general preventive measures. The identification of the environmental factors offers a real possibility to prevent the disease.


REFERENCES

  1. Burney PGJ. Epidemiologic trends. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock (eds) asthma. Lippincott-Raven Publishers, Philadelphia, 1997; 35-47.

  2. Bacon K, Schall T. Chemokines as mediators of allergic inflammation. Int Arch Allergy Immunol 1996; 109: 97-109.

  3. Kimata H, Yoshida A, Ishioka C, Fujimoto M, Lindley I, Furusho K. RANTES and macrophage inflammatory protein 1a selectively enhance IgE and IgG4 production by human B cells. J Exp Med 1996; 183: 2397-2402.

  4. Chandra KR. Five-year follow-up of high-risk infants with family history of allergy who were exclusively breast-fed or fed partial whey hydrolysate, say, and conventional cow’s milk formulas. J Pediatr Gastronterol Nutr 1997; 24: 442-446.

  5. Hopp RJ, Bewtra AK, Watt GD, Nair NM, Townley RG. Genetic analysis of allergic disease in twins. J Allergy Clin Immunol 1984; 73: 265-270.

  6. Howard T, Wiesch D, Koppelman H, Postma D, Meyers D, Bleecker E. Genetics of allergy and bronchial hyperresponsiveness. Clin Exp Allergy 1999; 29(Suppl 2): 86-89.

  7. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martínez FD. A polymorphism in the 5’ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-983.

  8. Moffatt M, Cookson W. Genetics of asthma and inflammation: the status. Current Opinion in Immunology 1999, 11: 606-9.

  9. Brown M, Halonen M. Perinatal events in the development of asthma. Current Opinion in Pulmonary Medicine 1999, 5: 4-9.

  10. Carlsen L, Carlsen KH, Nafstad C. Perinatal risk factors for recurrent wheeze in early life. Pediatr Allergy Immunol 1999; 160: 557-563.

  11. Fergusson DM, Crane J, Beasley R, Horwood LJ. Perinatal factors and atopic disease in childhood. Clin Exp Allergy 1997; 27: 1394-1401.

  12. Warner JA, Jones CA, Jones AC, Miles EA, Francis T, Warner JO. Immune responses during pregnancy and the development of allergic disease. Pediatr Allergy Immunol 1997; 8(suppl 10): 5-10.

  13. Holt PG. Primary allergic sensitization to environmental antigens: perinatal T-cell priming as a determinant of responder phenotype in adulthood. J Exp Med 1996; 183: 1297-1301.

  14. Holt PG, Naspitz Ch, Warner JO. Prevention of Allergy and Asthma: Early immunological influences. Allergy 2000; 55: 1075-1078.

  15. Saarinen UM, Kajoraari M. Breastfeeding as profilaxis against atopic disease: Prospective follow-up study until 17-years old. Lancet 1995; 346: 1065-1069.

  16. Kalliomäki M, Ouwehand A, Arvilommi H, Kero P, Isolauri E. Transforming growth factor-b in breast milk: A potential regulator of atopic disease at an early age. J Allergy Clin Immunol 1999; 1251-1257.

  17. Böttcher M. Cytokines and chemokines in breast milk from allergic and nonallergic mothers. ACI International 2000; 12: 153-160.

  18. Sears MR, Burrows B, Flannery EM, Herbison GP Holdaways MD. Atopy in childhood. I. Gender and allergen related risks for development of hay fever and asthma. Clin Exp Allergy 1993; 23: 941-948.

  19. Omenaas E, Bakke P, Elsayed E, Hanoa R, Gulsvik A. Total and specific IgE levels in adults: relationship to sex, age and environmental factors. Clin Exp Allergy 1994; 24: 530-539.

  20. De Swert LFA. Risk factors for allergy. Eur J Pediatr 1999; 158: 89-94.

  21. Barbee RA, Halonen M, Kaltenborn W, Lebowitz M, Burrows B. A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking and atopic status. J Allergy Clin Immun 1987; 79: 919-927.

  22. Grundbacher F. Causes of variation in serum IgE levels in normal populations. J Allergy Clin Immunol 1975; 56: 104-111.

  23. Wahn U, Chuchalin A, Kowalski ML. Prevention of Allergy and Asthma: Predictive and early diagnosis. Allergy 2000; 55: 1078-1080.

  24. Dunder T, Kuikka L, Turtinen J, Rasanen L, Uhari M. Diet, serum fatty acids, and atopic diseases in childhood. Allergy 2001; 56: 425-428.

  25. Apelberg BJ, Aoki Y, Jaakkola JJ. Systematic review: Exposure to pets and risk of asthma-like symptoms. J Allergy Clin Immunol 2001; 107: 455-460.

  26. Asher I, Dagli E, Holgate S. Prevention of Allergy and Asthma: Genetic and environmental influences. ACI International 2000; 12: 290-291.

  27. Rook GAW. Clean living increases more than just atopic disease. Immunol Today 2000; 21: 249-250.

  28. Arribas J, Gómez R, Sebastián A, Colás C. Factores pronósticos en el asma infantil: Papel de las infecciones. Alergol Immunol Clin 2000; 15: 59-63.

  29. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999; 402(supp): B5-B-11

  30. Morton RL, Sheik S, Corbett ML, Eid NS. Evaluation of the wheezy infant. Ann Allergy Clin Immunol 2001; 86: 251-256.

  31. Rojas-Garrido A, López-Pérez G, Orozco-Martínez S, Guerrero-Sánchez E, Huerta-López JG. Tabaquismo y desarrollo de alergia durante la infancia. Mecanismos fisiopatológicos. Alergia, Asma e Inmunología Pediátricas 2001; 10: 43-52.

  32. De Swert LFA. Risk factors for allergy. Eur J Pediatr 1999; 158: 89-94.

  33. Herz U, Lacy P, Renz H, Erb K. The influence of infections on the development and severity of allergic disorders. Curr Opin Immunol 2000; 12: 632-640.

  34. Douglass A, O’hehir R. What determines asthma phenotype? Am J Respir Crit Care Med 2000; 161(suppl 2): 211-214.

  35. Lewis S. Infections in asthma and allergy. Thorax 1998; 53: 911-912.

  36. Folkerts G, Walzl G, Openshaw PJM. Do common childhood infections teach the immune system not to be allergic? Immunol Today 2000; 21: 118-120.

  37. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trail. Lancet 2001; 357: 1076-1079.

  38. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275: 77-79.

  39. Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997; 350: 400-403.

  40. Wickens K, Crane J, Kemp T, Lewis S, D’Souza W, Sawyer G, Stone L, Tohill S, Kennedy J, Slater T, Rains N, Pearce N. A case-control study of risk factors for asthma in New Zealand children. Aust N Z J Public Health 2001; 25: 44-49.

  41. Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest 1997; 111: 1389-1402.

  42. Sheik S, Stephen T, Howell L. Gastroesophageal reflux in infants with wheezing. Pediatr Pulmonol 1999; 28: 181-186.

  43. Hamamoto J, Kohrogi H, Kawano O, Iwagoe H, Fukii K, Hirata N, et al. Esophageal stimulation by hydrochloric acid causes neurogenic inflammation in the airways of guinea pigs. J Appl Physiol 1997; 82: 738-745.

  44. Harding SM. Gastroesophageal reflux and asthma: Insight into the association. J Allergy Clin Immunol 1999; 104: 251-259.

  45. Vijayaratnam V, Lin CH, Simpson P. Lack of significant proximal esophageal acid reflux in infants presenting with respiratory symptoms. Pediatr Pulmonol 1999; 27: 231-235.

  46. Schindlbeck NE, Heinrich C, Huber RM, Müller-Lissner SA: Effects of albuterol (salbutamol) on esophageal motility and gastroesophageal reflux in healthy volunteers. JAMA 1988; 260: 3156:3158.

  47. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ, and the Group Health Medical Associates. Asthma and wheezing in the first six year of life. N Engl J Med 1995; 332: 133-138.

  48. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM, and the Group Health Medical Associates’ Personnel. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319: 1112-1117.

  49. Martinez MD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune responses to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol 1998; 102: 915-20.

  50. Martinez FD. Viral Infections and the development of asthma. Am J Respir Crit Care Med 1995; 151: 1644-1648.




2020     |     www.medigraphic.com